Literature DB >> 11160128

Sarcoglycan, the heart, and skeletal muscles: new treatment, old drug?

J A Towbin1, N E Bowles.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11160128      PMCID： PMC199185          DOI： 10.1172/JCI11998

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  13 in total

Review 1.  The role of cytoskeletal proteins in cardiomyopathies.

Authors:  J A Towbin
Journal:  Curr Opin Cell Biol       Date:  1998-02       Impact factor: 8.382

2.  Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.

Authors:  R D Cohn; M Durbeej; S A Moore; R Coral-Vazquez; S Prouty; K P Campbell
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 3.  The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy.

Authors:  N E Bowles; K R Bowles; J A Towbin
Journal:  Herz       Date:  2000-05       Impact factor: 1.443

4.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.

Authors:  D Fatkin; C MacRae; T Sasaki; M R Wolff; M Porcu; M Frenneaux; J Atherton; H J Vidaillet; S Spudich; U De Girolami; J G Seidman; C Seidman; F Muntoni; G Müehle; W Johnson; B McDonough
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

5.  Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy.

Authors:  S Tsubata; K R Bowles; M Vatta; C Zintz; J Titus; L Muhonen; N E Bowles; J A Towbin
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 6.  Dystrophies and heart disease.

Authors:  G F Cox; L M Kunkel
Journal:  Curr Opin Cardiol       Date:  1997-05       Impact factor: 2.161

7.  Mapping a cardiomyopathy locus to chromosome 3p22-p25.

Authors:  T M Olson; M T Keating
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

8.  X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus.

Authors:  J A Towbin; J F Hejtmancik; P Brink; B Gelb; X M Zhu; J S Chamberlain; E R McCabe; M Swift
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

9.  Heart involvement in muscular dystrophies due to sarcoglycan gene mutations.

Authors:  P Melacini; M Fanin; D J Duggan; M P Freda; A Berardinelli; G A Danieli; A Barchitta; E P Hoffman; S Dalla Volta; C Angelini
Journal:  Muscle Nerve       Date:  1999-04       Impact factor: 3.217

10.  Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement.

Authors:  G L Brodsky; F Muntoni; S Miocic; G Sinagra; C Sewry; L Mestroni
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690
View more
  2 in total

1.  Role of proteases in the pathophysiology of cardiac disease.

Authors:  Raja B Singh; Sucheta P Dandekar; Vijayan Elimban; Suresh K Gupta; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

2.  Sarcolemmal fragility secondary to the degradation of dystrophin in dilated cardiomyopathy, as estimated by electron microscopy.

Authors:  Tomie Kawada; Chieko Hemmi; Satoru Fukuda; Asaki Tezuka; Kuniaki Iwasawa; Mikio Nakazawa; Hiroshi Sato; Teruhiko Toyo-Oka
Journal:  Exp Clin Cardiol       Date:  2003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.